This study is testing a medicine called Suzetrigine (SUZ) to see if it helps with pain from diabetic peripheral neuropathy (DPN). DPN is a condition where nerves in the arms and legs are damaged because of diabetes, causing pain. Participants need to have had diabetes for at least one year and a certain level of pain to join. They must weigh at least 45 kilograms (about 99 pounds) and have a body mass index (BMI) between 18 and 40. BMI is a measure of body fat based on height and weight.
Participants cannot join if they miss too many pain score records in the first week or have recently taken a drug called Journavx. The study wants to know if Suzetrigine is safe and if it works well for pain.
- Study Duration: This will involve multiple visits over a specified period.
- Potential Risks: Include typical medication side effects, which will be monitored.
- Compensation: Participants may receive compensation for their time and travel.